MedElevator Войти в исследования
← Поиск публикаций

DOI 10.7759/cureus.96517

Медицинская библиотека · Cureus · 2025

Neoadjuvant Radiochemotherapy and Total Neoadjuvant Therapy in the Management of Locally Advanced Rectal Cancer.

Yigit Mücahit, Roohani Siyer, Kurreck Annika, Siegel Robert, Modest Dominik P, Kaul David, Ehret Felix

СтатьяПеревод пока не подготовлен

Аннотация

Neoadjuvant radiochemotherapy is a key treatment modality for locally advanced rectal cancer (LARC). Total neoadjuvant therapy (TNT) is a relatively new treatment approach consisting of neoadjuvant radiochemotherapy and consolidative or inductive chemotherapy followed by curative resection. In this study, we aimed to assess the treatment outcomes at a tertiary care center, focusing on neoadjuvant treatments, and to compare our results to the available literature.

Methods

This retrospective cohort study included patients with LARC receiving TNT or neoadjuvant radiochemotherapy without postoperative chemotherapy between 2014 and 2023.

Results

A total of 122 patients with LARC, with a median follow-up of 21.4 months, were included. Thirty-one patients received TNT (25.4%). Ninety-one patients (74.6%) received long-course radiochemotherapy. Sixty-eight patients (55.7%) were classified as high-risk. Twenty-six cases of distant metastases (21.3%) and nine cases of local recurrence (7.4%) were observed. Five-year progression-free and distant metastasis-free survival rates were 62.9% and 68.3%, respectively. The five-year local control was 92.7%. Poor post-treatment tumor regression grading (TRG) in the surgical specimen was found to be associated with worse progression-free survival (hazard ratio (HR): 2.55, p=0.028). Tumors in the lower rectum were associated with worse local control (HR: 5.70; p=0.044).

Conclusions

Neoadjuvant radiochemotherapy, including TNT, for the treatment of LARC appears to be a safe and effective treatment option. TRG may play a role in identifying patients at high risk of early progression. Further research is warranted to determine the optimal TNT sequence and to improve patient selection to avoid over- and undertreatment.

Для цитирования: Yigit Mücahit, Roohani Siyer, Kurreck Annika, Siegel Robert, Modest Dominik P, Kaul David, Ehret Felix. Neoadjuvant Radiochemotherapy and Total Neoadjuvant Therapy in the Management of Locally Advanced Rectal Cancer.. Cureus. 2025. DOI: 10.7759/cureus.96517.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.